LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Trametinib | 3.33 | uM | LJP5 | 2 | P20 | 72 | hr | 1097 | 2877 | 3877 | 0.7419 | 0.6977 |
BT-20 | Trametinib | 3.33 | uM | LJP5 | 3 | P20 | 72 | hr | 1097 | 2622 | 3925 | 0.6680 | 0.6059 |
BT-20 | Trametinib | 10 | uM | LJP5 | 1 | P19 | 72 | hr | 1097 | 2722 | 3735 | 0.7287 | 0.6721 |
BT-20 | Trametinib | 10 | uM | LJP5 | 2 | P19 | 72 | hr | 1097 | 3100 | 3877 | 0.7994 | 0.7687 |
BT-20 | Trametinib | 10 | uM | LJP5 | 3 | P19 | 72 | hr | 1097 | 2926 | 3925 | 0.7454 | 0.7047 |
BT-20 | Omipalisib | 0.04 | uM | LJP6 | 1 | N06 | 72 | hr | 1097 | 740 | 3610 | 0.2050 | -0.2049 |
BT-20 | Omipalisib | 0.04 | uM | LJP6 | 2 | N06 | 72 | hr | 1097 | 818 | 3713 | 0.2203 | -0.1538 |
BT-20 | Omipalisib | 0.04 | uM | LJP6 | 3 | N06 | 72 | hr | 1097 | 776 | 3696 | 0.2099 | -0.1794 |
BT-20 | Omipalisib | 0.12 | uM | LJP6 | 1 | N05 | 72 | hr | 1097 | 765 | 3610 | 0.2119 | -0.1893 |
BT-20 | Omipalisib | 0.12 | uM | LJP6 | 2 | N05 | 72 | hr | 1097 | 694 | 3713 | 0.1869 | -0.2293 |
BT-20 | Omipalisib | 0.12 | uM | LJP6 | 3 | N05 | 72 | hr | 1097 | 728 | 3696 | 0.1970 | -0.2088 |
BT-20 | Omipalisib | 0.37 | uM | LJP6 | 1 | N04 | 72 | hr | 1097 | 647 | 3610 | 0.1792 | -0.2647 |
BT-20 | Omipalisib | 0.37 | uM | LJP6 | 2 | N04 | 72 | hr | 1097 | 590 | 3713 | 0.1589 | -0.2972 |
BT-20 | Omipalisib | 0.37 | uM | LJP6 | 3 | N04 | 72 | hr | 1097 | 589 | 3696 | 0.1593 | -0.2989 |
BT-20 | Omipalisib | 1.11 | uM | LJP6 | 1 | N03 | 72 | hr | 1097 | 475 | 3610 | 0.1316 | -0.3857 |
BT-20 | Omipalisib | 1.11 | uM | LJP6 | 2 | N03 | 72 | hr | 1097 | 499 | 3713 | 0.1344 | -0.3611 |
BT-20 | Omipalisib | 1.11 | uM | LJP6 | 3 | N03 | 72 | hr | 1097 | 564 | 3696 | 0.1526 | -0.3160 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1097 | 483 | 3610 | 0.1338 | -0.3797 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 1097 | 499 | 3713 | 0.1344 | -0.3611 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 1097 | 493 | 3696 | 0.1334 | -0.3666 |
BT-20 | Omipalisib | 10 | uM | LJP6 | 1 | N01 | 72 | hr | 1097 | 378 | 3610 | 0.1047 | -0.4622 |
BT-20 | Omipalisib | 10 | uM | LJP6 | 2 | N01 | 72 | hr | 1097 | 466 | 3713 | 0.1255 | -0.3855 |
BT-20 | Omipalisib | 10 | uM | LJP6 | 3 | N01 | 72 | hr | 1097 | 440 | 3696 | 0.1190 | -0.4064 |
BT-20 | Buparlisib | 0.04 | uM | LJP5 | 1 | H06 | 72 | hr | 1097 | 3693 | 3735 | 0.9887 | 0.9872 |
BT-20 | Buparlisib | 0.04 | uM | LJP5 | 2 | H06 | 72 | hr | 1097 | 4034 | 3877 | 1.0403 | 1.0438 |